-
Product Insights
Systemic Sclerosis (Scleroderma) - Drugs In Development, 2024
Empower your strategies with our Systemic Sclerosis (Scleroderma) – Drugs In Development, 2024 report and make more profitable business decisions. Scleroderma is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Symptoms include muscle pain, joint pain and swelling, ulcers occurring on the fingertips, bloating, and diarrhea or constipation. Treatment includes antibiotics, pain relievers, and immunosuppressants. The Systemic Sclerosis (Scleroderma) drugs in development market research report provide comprehensive information on the therapeutics under...
-
Product Insights
Food Allergy - Drugs In Development, 2024
Empower your strategies with our Food Allergy – Drugs In Development, 2024 report and make more profitable business decisions. Food allergies are immune system reactions to certain proteins in food. Symptoms range from mild itching to severe anaphylaxis, involving difficulty breathing and a drop in blood pressure, which can be life-threatening. Common allergens include peanuts, tree nuts, shellfish, eggs, milk, wheat, and soy. Strict avoidance and preparedness for accidental exposure are crucial. Diagnosis involves tests like skin prick or blood tests,...
-
Product Insights
Lupus Nephritis - Drugs In Development, 2024
Empower your strategies with our Lupus Nephritis – Drugs In Development, 2024 report and make more profitable business decisions. Lupus nephritis is a severe complication of systemic lupus erythematosus (SLE), an autoimmune disease that affects various organs, tissues, and systems within the body. Lupus nephritis specifically involves inflammation of the kidneys, leading to kidney damage and impaired kidney function. In systSLE, the body's immune system mistakenly attacks its own tissues and organs, including the kidneys, causing inflammation. Not all individuals with...
-
Product Insights
Myasthenia Gravis - Drugs In Development, 2024
Empower your strategies with our Myasthenia Gravis – Drugs In Development, 2024 report and make more profitable business decisions. Myasthenia gravis is an autoimmune neuromuscular disease characterized by weakness and rapid fatigue of any of the muscles under voluntary control. Symptoms include drooping of one or both eyelids, diplopia, and difficulty swallowing, chewing, and speaking. Treatment includes immunosuppressants, corticosteroids, and surgery. The Myasthenia Gravis drugs in development market research report provide comprehensive information on the therapeutics under development for Myasthenia Gravis,...
-
Product Insights
Sicca Syndrome (Sjogren) - Drugs In Development, 2024
Empower your strategies with our Sicca Syndrome (Sjogren) – Drugs In Development, 2024 report and make more profitable business decisions. Sjogren's syndrome is an autoimmune disease. It involves the inflammation of glands and other tissues of the body. Symptoms include skin rashes or dry skin, vaginal dryness, persistent dry cough, prolonged fatigue, dry eye, dry mouth, joint pain, swelling, and stiffness. Predisposing factors include age, sex, and rheumatic disease. The Sicca Syndrome (Sjogren) drugs in development market research report provide comprehensive...
-
Product Insights
Kidney Transplant Rejection - Drugs In Development, 2024
Empower your strategies with our Kidney Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Kidney transplantation is a therapy performed to replace a diseased kidney with a healthy kidney from another person. Risk factors associated with transplantation are bleeding, infection, blockage of the blood vessels to the new kidney, leakage of urine or blockage of urine in the ureter, and initial lack of function of the new kidney. Treatment includes immunosuppressive drugs to prevent organ...
-
Product Insights
Peanut Allergy - Drugs In Development, 2024
Empower your strategies with our Peanut Allergy – Drugs In Development, 2024 report and make more profitable business decisions. Peanut allergy is common, especially in children. An allergic response to peanuts usually occurs within minutes after exposure, and symptoms range from mild to severe. Peanut allergy signs and symptoms can include skin reactions such as hives, redness or swelling; itching or tingling in or around the mouth and throat; digestive problems, such as diarrhea, stomach cramps, nausea or vomiting; tightening of...
-
Product Insights
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) - Drugs In Development, 2024
Empower your strategies with our Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) – Drugs In Development, 2024 report and make more profitable business decisions. Anti-neutrophil cytoplasmic antibody-associated (ANCA) vasculitis is a group of autoimmune diseases that cause inflammation and damage to small blood vessels. It is triggered by autoantibodies called ANCAs that target and attack neutrophils, a type of white blood cell. ANCA vasculitis can affect different organs or parts of the body, such as the skin, kidney, or lung. The symptoms,...
-
Product Insights
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Drugs In Development, 2024
Empower your strategies with our Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) – Drugs In Development, 2024 report and make more profitable business decisions. Hereditary angioedema (HAE) is a rare inherited disease that causes considerable swelling in various body tissues, such as the abdomen or face. Symptoms include severe abdominal pain and cramping, dehydration, diarrhea and shock, hoarse voice, difficulty swallowing,and difficulty breathing. Treatment includes medications such as epinephrine, antihistamines, and corticosteroids. The Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH]...
-
Product Insights
Pollen Allergy - Drugs In Development, 2024
Empower your strategies with our Pollen Allergy – Drugs In Development, 2024 report and make more profitable business decisions. Pollen allergy, characterized by sensitivity to the minute particles released seasonally by trees, grasses, and weeds, occurs when these pollen grains disperse through the air in their journey to fertilize plants. The particles frequently infiltrate noses, eyes, ears, and mouths, instigating the onset of allergy symptoms. Sneezing, nasal congestion, and itchy eyes are common manifestations of the immune system's response to these...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.